Nurix Therapeutics (NRIX) Share-based Compensation (QoQ) (2019 - 2026)
Nurix Therapeutics (NRIX) Share-based Compensation (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 564.41% |
| Feb 28, 2026 | 109.43% |
| Nov 30, 2025 | -395.32% |
| Aug 31, 2025 | -5.90% |
| May 31, 2025 | 19.07% |
| Feb 28, 2025 | -73.27% |
| Nov 30, 2024 | 312.31% |
| Aug 31, 2024 | -273.77% |
| May 31, 2024 | 13.08% |
| Feb 29, 2024 | -76.72% |
| Nov 30, 2023 | 134,304.00% |
| Aug 31, 2023 | 8.70% |
| May 31, 2023 | -4.17% |
| Feb 28, 2023 | -99.91% |
| Nov 30, 2022 | -67.25% |
| Aug 31, 2022 | 25.95% |
| May 31, 2022 | 1,023.37% |
| Feb 28, 2022 | 25.36% |
| Nov 30, 2021 | 118.94% |
| Aug 31, 2021 | 9.78% |